Paris - Delayed Quote EUR

Neurones S.A. (NRO.PA)

47.80
+0.60
+(1.27%)
At close: May 9 at 5:35:14 PM GMT+2
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
810,353
810,353
741,175
665,379
579,879
Cost of Revenue
304,175
304,175
284,464
256,165
231,647
Gross Profit
506,178
506,178
456,711
409,214
348,232
Operating Expense
428,171
428,171
381,684
337,272
286,675
Operating Income
78,007
78,007
75,027
71,942
61,557
Net Non Operating Interest Income Expense
10,026
10,026
4,483
-42
184
Pretax Income
88,110
88,110
80,765
72,862
61,759
Tax Provision
24,882
24,882
22,183
21,091
18,819
Net Income Common Stockholders
52,556
52,556
49,410
44,243
37,706
Diluted NI Available to Com Stockholders
52,556
52,556
49,410
44,243
37,706
Basic EPS
2.00
2.17
2.04
1.83
1.56
Diluted EPS
1.99
2.16
2.03
1.82
1.56
Basic Average Shares
24,262.66
24,272.14
24,237.98
24,222.97
24,215.66
Diluted Average Shares
24,328.92
24,346.39
24,313.23
24,289.94
24,247.41
Total Operating Income as Reported
77,920
77,920
75,857
72,893
61,573
Rent Expense Supplemental
4,888
4,888
4,086
2,923
2,708
Total Expenses
732,346
732,346
666,148
593,437
518,322
Net Income from Continuing & Discontinued Operation
52,556
52,556
49,410
44,243
37,706
Normalized Income
52,373.73
52,373.73
48,256.71
43,743.17
37,753.96
Interest Income
11,845
11,845
5,917
1,661
1,150
Interest Expense
1,819
1,819
1,434
1,703
966
Net Interest Income
10,026
10,026
4,483
-42
184
EBIT
89,929
89,929
82,199
74,565
62,725
EBITDA
107,584
107,584
98,956
91,139
77,530
Reconciled Cost of Revenue
304,175
304,175
284,464
256,165
231,647
Reconciled Depreciation
17,655
17,655
16,757
16,574
14,683
Net Income from Continuing Operation Net Minority Interest
52,556
52,556
49,410
44,243
37,706
Total Unusual Items Excluding Goodwill
254
254
1,590
703
-69
Total Unusual Items
254
254
1,590
703
-69
Normalized EBITDA
107,330
107,330
97,366
90,436
77,599
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
71.73
71.73
436.71
203.17
-21.05
12/31/2021 - 5/24/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers